Beneficial Effect of Donepezil Augmentation for the Management of Comorbid Schizophrenia and Dementia

“Mini-mental state”

1975 • 82,784 citations

The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

1987 • 19,723 citations

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

1998 • 1,575 citations

Neuropsychological Deficits in Neuroleptic Naive Patients With First-Episode Schizophrenia

1994 • 1,099 citations

Limits of the ‘Mini-Mental State’ as a screening test for dementia and delirium among hospital patients

1982 • 1,094 citations

Schizophrenics Show Spatial Working Memory Deficits

1992 • 953 citations

Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia

1995 • 676 citations

Further Evidence for Dementia of the Prefrontal Type in Schizophrenia?

1987 • 524 citations

Neuropsychological Deficits in Schizophrenics

1994 • 387 citations

Neuropsychological functioning of first-episode schizophreniform patients

1992 • 324 citations

Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study

2000 • 265 citations

Nicotinic Receptor Function in Schizophrenia

1996 • 261 citations

The Disabilities of Chronic Schizophrenia—their Nature and the Factors Contributing to their Development

1980 • 258 citations

Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation

2000 • 219 citations

Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.

1996 • 200 citations

The Effect of Neuroleptics on Cognitive and Psychomotor Function

1990 • 191 citations

Postmortem Studies in Schizophrenia

1998 • 187 citations

A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia

2002 • 169 citations

Pharmacologic strategies for augmenting cognitive performance in schizophrenia

1999 • 142 citations

Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia

1999 • 135 citations

Cognitive Function in Schizophrenia— Do Neuroleptics Make a Difference?

1997 • 128 citations

Cholinergic aspects of schizophrenia

1999 • 118 citations

Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease

1996 • 117 citations

Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release

1999 • 103 citations

Schizophrenia and Alzheimer's disease: Clinical and pathophysiologic analogies

1996 • 82 citations

A Double-blind Placebo-controlled Case Study of the Use of Donepezil to Improve Cognition in a Schizoaffective Disorder Patient: Functional MRI Correlates.

2001 • 52 citations

Decreased mesopontine choline acetyltransferase levels in schizophrenia

1996 • 45 citations

Cognitive functioning in chronically hospitalized schizophrenic patients: age-related changes and age disorientation as a predictor of impairment

1995 • 41 citations

Age Disorientation in Schizophrenia: A Constant Prevalence of 25 per cent in a Chronic Mental Hospital Population?

1978 • 41 citations

No neuropathologic evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics

1998 • 27 citations

Comparison of Two Cognitive Rating Scales in Medically Ill Patients

1988 • 23 citations